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A, adrenaline; ACTH, adrenocorticotropic hormone; AF1/2, activation function 1/2; AP-1, 
activation protein-1; BDNF, brain-derived neurotrophic factor; BLA, basolateral nucleus of 
the amygdala; cAMP, cyclic adenosine monophosphate; CeA, central nucleus of the amyg-
dala; con, control; CORT, corticosterone; (p)CREB, (phosphorylated) cyclic adenosine 
monophosphate response element binding protein; CRH, corticotropin releasing hormone; 
DG, dentate gyrus of the hippocampus; DMH, dorsomedial nucleus of the hypothalamus; 
dp, dorsal parvocellular part of the PVN; DPN, diarylpropionitrile; DSM-IV, Diagnostic 
and Statistical Manual of mental disorders IV; E2, 17β-estradiol benzoate; eNOS, endothe-
lial nitric oxide synthase; ER(α or β), estrogen receptor (α or β); ERE, estrogen responsive 
element; (p)ERK1/2, (phosphorylated) extracellular-regulated kinase 1/2; ERT, estrogen 
replacement therapy; FSH, follicle-stimulating hormone; GABA, gamma aminobutyric 
acid; GR, glucocorticoid receptor; HPA-axis, hypothalamic-pituitary-adrenal axis; HPLC, 
high performance liquid chromotography; IL, infralimbic area of the mPFC; LH, lutein-
izing hormone; MAOI, monoamine oxidase inhibitor; MAPk, mitogen-activated protein 
kinase; MeA, medial nucleus of the amygdala; mER-X, membrane-bound estrogen recep-
tor; MIR, mirtazapine; mpd, dorsomedial parvocellular zone of the PVN; mpv, ventral me-
dial parvocellular part of the PVN; MR, mineralocorticoid receptor; NA, noradrenaline; 
NF-κB, nuclear factor-κB; NGF, nerve growth factor; NO , nitric oxide; OCD, obsessive 
compulsive disorder; OF, open field; OFQ, orphanin FQ; ORL-1, opioid receptor-like-
1; OT, oxytocin; OVX, ovariectomy; PBS, phosphate buffered saline; PDD, postpartum 
depression; (m)PFC, (medial) prefrontal cortex; PL, prelimbic area of the mPFC; pml, 
posterior magnocellular division of the PVN; PMS, premenstrual syndrome; PPT, propyl 
pyrazole triol; PTSD, posttraumatic stress disorder; PVN, paraventricular nucleus of the 
hypothalamus; rec, recovery; RFLP, restriction fragment length polymorphism; rtPCR, 
real time polymerase chain reaction; SERM, specific estrogen receptor modulator; Sp-1, 
specificity protein-1; SSRI, selective serotonin re-uptake inhibitor; TCA, tricycic antide-
pressant; VEH, vehicle; WHI, Women’s Health Initiative.
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